1. Home
  2. MRSN vs IZM Comparison

MRSN vs IZM Comparison

Compare MRSN & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • IZM
  • Stock Information
  • Founded
  • MRSN 2001
  • IZM 2011
  • Country
  • MRSN United States
  • IZM China
  • Employees
  • MRSN N/A
  • IZM N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • MRSN Health Care
  • IZM Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • IZM Nasdaq
  • Market Cap
  • MRSN 37.0M
  • IZM 31.8M
  • IPO Year
  • MRSN 2017
  • IZM 2023
  • Fundamental
  • Price
  • MRSN $7.24
  • IZM $2.35
  • Analyst Decision
  • MRSN Strong Buy
  • IZM
  • Analyst Count
  • MRSN 4
  • IZM 0
  • Target Price
  • MRSN $63.67
  • IZM N/A
  • AVG Volume (30 Days)
  • MRSN 138.9K
  • IZM 35.2K
  • Earning Date
  • MRSN 08-13-2025
  • IZM 08-26-2025
  • Dividend Yield
  • MRSN N/A
  • IZM N/A
  • EPS Growth
  • MRSN N/A
  • IZM N/A
  • EPS
  • MRSN N/A
  • IZM N/A
  • Revenue
  • MRSN $34,769,000.00
  • IZM $180,553,977.00
  • Revenue This Year
  • MRSN N/A
  • IZM N/A
  • Revenue Next Year
  • MRSN $1.03
  • IZM N/A
  • P/E Ratio
  • MRSN N/A
  • IZM N/A
  • Revenue Growth
  • MRSN 16.14
  • IZM N/A
  • 52 Week Low
  • MRSN $5.21
  • IZM $1.18
  • 52 Week High
  • MRSN $70.75
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 48.99
  • IZM 34.07
  • Support Level
  • MRSN $5.21
  • IZM $2.52
  • Resistance Level
  • MRSN $7.68
  • IZM $2.61
  • Average True Range (ATR)
  • MRSN 0.54
  • IZM 0.09
  • MACD
  • MRSN 0.12
  • IZM -0.02
  • Stochastic Oscillator
  • MRSN 81.04
  • IZM 3.45

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: